Photo by schluditsch from unsplash
Rifampicin is an essential first line anti‐tuberculosis drug. However, several cases of adverse reactions associated with this drug have been reported, the most common of which are cutaneous drug reactions.… Click to show full abstract
Rifampicin is an essential first line anti‐tuberculosis drug. However, several cases of adverse reactions associated with this drug have been reported, the most common of which are cutaneous drug reactions. We report a case of mixed lichenoid and psoriasiform drug eruption induced by rifampicin.
Keywords:
mixed lichenoid;
lichenoid psoriasiform;
drug;
eruption induced;
psoriasiform drug;
drug eruption
Journal Title: Australasian Journal of Dermatology
Year Published: 2019
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Australasian Journal of Dermatology
Year Published: 2019
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!